FACTOR CERTIFICATE LONG - NOVARTIS N Share Price

Certificat

L8NOXU

CH0486384834

Market Closed - Swiss Exchange 08:50:00 10/05/2024 pm IST
0.1 CHF +25.00% Intraday chart for FACTOR CERTIFICATE LONG - NOVARTIS N
3 months+42.86%
6 months+66.67%
Date Price Change Volume

Delayed Quote Swiss Exchange

Last update May 10, 2024 at 08:50 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying NOVARTIS AG
Issuer UBS
L8NOXU
ISINCH0486384834
Date issued 15/07/2019
Strike 84.74 CHF
Maturity Unlimited
Parity 138.56 : 1
Emission price 4.93 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 7.84 CHF
Lowest since issue 0.03 CHF
Spread 0.01 CHF
Spread %9.09%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.8 USD
Average target price
108.4 USD
Spread / Average Target
+6.52%
Consensus
  1. Stock Market
  2. Certificates
  3. L8NOXU Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW